Loading
CombiMatrix Corp is a listed company. Its insiders report their share dealings to SEC (Form 4). No insider at CombiMatrix Corp has published a filing in the past twelve months. The most recent one dates from 13 January 2016.
In the same market, recent insider purchases at Relmada Therapeutics, Inc. and Uber Technologies, Inc also feature in our signals. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
FY ended December 2016 · cache
4 of 4 declarations
CombiMatrix Corp is a company focused on developing genetic diagnostic solutions. It offers tests based on advanced technologies to aid in the detection of genetic diseases.